AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Semaglutide for HFpEF and TCAs for IBS
This chapter explores the potential benefits of semaglutide for heart failure with preserved ejection fraction (HFpEF) and discusses the Atlantis trial, investigating tricyclic antidepressants for irritable bowel syndrome (IBS). Details about the trial, including patient enrollment and dosage, are provided.